Literature DB >> 12640176

Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia.

Kathryn H Adcock1, Johann Nedelcu, Thomas Loenneker, Ernst Martin, Theo Wallimann, Bendicht P Wagner.   

Abstract

We hypothesized that creatine (Cr) supplementation would preserve energy metabolism and thus ameliorate the energy failure and the extent of brain edema seen after severe but transient cerebral hypoxia-ischemia (HI) in the neonatal rat model. Six-day-old (P6) rats received subcutaneous Cr monohydrate injections for 3 consecutive days (3 g/kg body weight/day), followed by 31P-magnetic resonance spectroscopy (MRS) at P9. In a second group, P4 rats received the same Cr dose as above for 3 days prior to unilateral common carotid artery ligation followed 1 h later by 100 min of hypoxia (8% O2) at P7. Rats were maintained at 37 degrees C rectal temperature until magnetic resonance imaging was performed 24 h after HI. Cr supplementation for 3 days significantly increased the energy potential, i.e. the ratio of phosphocreatine to beta-nucleotide triphosphate (PCr/betaNTP) and PCr/inorganic phosphate (PCr/Pi) as measured by 31P-MRS. Rats with hemispheric cerebral hypoxic-ischemic insult that had received Cr showed a significant reduction (25%) of the volume of edemic brain tissue compared with controls as calculated from diffusion-weighted images (DWI). Thus, prophylactic Cr supplementation demonstrated a significant neuroprotective effect 24 h after transient cerebral HI. We hypothesize that neuroprotection is probably due to the availability of a larger metabolic substrate pool leading to a reduction of the secondary energy failure because DWI has been reported to correlate with the PCr/Pi ratio in the acute phase of injury. Additional protection by Cr may be related to prevention of calcium overload, prevention of mitochondrial permeability transition pore opening and direct antioxidant effects. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12640176     DOI: 10.1159/000069043

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  21 in total

1.  Hypoxic-ischemic brain injury in the neonatal rat model: relationship between lesion size at early MR imaging and irreversible infarction.

Authors:  Y Wang; P-T Cheung; G X Shen; E X Wu; G Cao; I Bart; W H S Wong; P-L Khong
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

Review 2.  The creatine kinase system and pleiotropic effects of creatine.

Authors:  Theo Wallimann; Malgorzata Tokarska-Schlattner; Uwe Schlattner
Journal:  Amino Acids       Date:  2011-03-30       Impact factor: 3.520

Review 3.  Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.

Authors:  Mary C McKenna; Susanna Scafidi; Courtney L Robertson
Journal:  Neurochem Res       Date:  2015-07-07       Impact factor: 3.996

4.  AltitudeOmics: Red Blood Cell Metabolic Adaptation to High Altitude Hypoxia.

Authors:  Angelo D'Alessandro; Travis Nemkov; Kaiqi Sun; Hong Liu; Anren Song; Andrew A Monte; Andrew W Subudhi; Andrew T Lovering; Daniel Dvorkin; Colleen G Julian; Christopher G Kevil; Gopi K Kolluru; Sruti Shiva; Mark T Gladwin; Yang Xia; Kirk C Hansen; Robert C Roach
Journal:  J Proteome Res       Date:  2016-09-27       Impact factor: 4.466

Review 5.  Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers.

Authors:  Olivier Braissant
Journal:  J Inherit Metab Dis       Date:  2012-01-18       Impact factor: 4.982

Review 6.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 7.  Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury.

Authors:  Courtney L Robertson; Susanna Scafidi; Mary C McKenna; Gary Fiskum
Journal:  Exp Neurol       Date:  2009-05-07       Impact factor: 5.330

Review 8.  Creatine Supplementation for Patients with Inflammatory Bowel Diseases: A Scientific Rationale for a Clinical Trial

Authors:  Theo Wallimann; Caroline H T Hall; Sean P Colgan; Louise E Glover
Journal:  Nutrients       Date:  2021-04-23       Impact factor: 5.717

9.  Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.

Authors:  Richard Kones
Journal:  Clin Pharmacol       Date:  2010-09-17

10.  Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation.

Authors:  Vishal Jain; Iswar Baitharu; Dipti Prasad; Govindasamy Ilavazhagan
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.